Silica Microsphere Topical Compositions for Reduced Skin Irritation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Topical pharmaceutical products often cause skin or mucosa irritation due to active ingredients like retinoids, benzoyl peroxide, hydroquinone, and 5-fluorouracil, leading to severe side effects such as redness, swelling, and itching, and existing formulations do not adequately address these issues.
Innovation Solution
The development of sustained release compositions incorporating silica microspheres with active ingredients such as adapalene, tazarotene, tretinoin, benzoyl peroxide, or combinations thereof, which provide a slow and controlled release of the active compounds, reducing irritation and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional topical formulations containing active ingredients (retinoids, benzoyl peroxide, hydroquinone, 5-fluorouracil) are used, then therapeutic effectiveness is achieved, but skin irritation and inflammation increase
Solution Approach 1:
The active ingredient is segmented and loaded into individual silica microspheres, which are then dispersed throughout the topical composition. This segmentation allows controlled release of the active ingredient over time, reducing the immediate irritant effect while maintaining therapeutic effectiveness.
Solution Approach 2:
Silica microspheres serve as an intermediary carrier between the active ingredient and the skin. The microspheres control the release kinetics of the active ingredient, acting as a buffer that reduces direct contact between the irritant active ingredient and the skin, thereby reducing irritation while maintaining efficacy.
2Reliability
If high concentrations of active ingredients are used to ensure therapeutic effect, then treatment effectiveness improves, but side effects and irritation increase
Solution Approach 1:
The silica microsphere formulation provides continuous, sustained release of the active ingredient over an extended period. This continuous action allows the use of lower initial concentrations while maintaining therapeutic effectiveness through prolonged release, thereby reducing acute adverse reactions.
Solution Approach 2:
The release parameters of the active ingredient are changed by incorporating it into silica microspheres with specific size distributions (0.5-40 microns). This parameter change in the physical state and release kinetics allows controlled, gradual release that reduces irritation while maintaining cumulative therapeutic effect.
3Speed
If rapid release of active ingredient is achieved for immediate effect, then quick treatment response is obtained, but irritation and inflammation increase
Solution Approach 1:
The release dynamics of the active ingredient are made adjustable through the silica microsphere formulation. The system transitions from rapid initial release to sustained slow release, allowing immediate treatment effect while the gradual release portion reduces irritation and inflammation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions offer improved stability and reduced skin irritation, providing effective treatment for skin disorders like acne, psoriasis, and actinic keratosis while minimizing adverse reactions.
Implementation Method 1
sustained release compositions... provide a slow and controlled release of the active compounds
Implementation Method 2
silica microspheres, formed prior to contact with the active ingredient, impregnated with the active ingredient
Data Source
AI summary
A topical composition which includes a silica microspheres and an active ingredient in the amount of 0.01 to 15.0% w/w wherein the active ingredient is selected from adapalene, an antibiotic, tazarotene, tretinoin, a retinoid, or any combination thereof. The topical composition may also include benzoyl peroxide as an active ingredient. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.